Matches in SemOpenAlex for { <https://semopenalex.org/work/W2404805773> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2404805773 endingPage "84" @default.
- W2404805773 startingPage "1079" @default.
- W2404805773 abstract "The combinations of doxorubicin (40 mg/m2 iv every 3 weeks) and mitomycin (12 mg/m2 iv every 6 weeks) or cisplatin (80 mg/m2 iv every 3 weeks X 3, then every 6 weeks) and etoposide (80 mg/m2 iv on Days 1-3 every 3 weeks X 3, then every 6 weeks) were evaluated in a randomized phase II trial in 77 patients with measurable or evaluable non-small cell lung cancer. No patient had been pretreated with prior chemotherapy. The overall response rate for the doxorubicin and mitomycin regimen was 11% and for the cisplatin and etoposide regimen was 23%. Responses lasted a median of 5.5 months. Median survival was 7.0 months for the doxorubicin and mitomycin regimen and 8.0 months for the cisplatin and etoposide regimen. One treatment-related death was observed after doxorubicin and mitomycin in a patient who had received radiation therapy immediately prior to study entry. Otherwise, the hematologic toxicity of both chemotherapy regimens was moderate, with only six patients (10%) having World Health Organization grade 3 toxicity and no patients having World Health Organization grade 4 toxicity. However, subjective tolerance gastrointestinal upset) of the cisplatin and etoposide combination was poor." @default.
- W2404805773 created "2016-06-24" @default.
- W2404805773 creator A5006722970 @default.
- W2404805773 creator A5009811110 @default.
- W2404805773 creator A5029738724 @default.
- W2404805773 creator A5036344172 @default.
- W2404805773 creator A5041616863 @default.
- W2404805773 creator A5058713571 @default.
- W2404805773 creator A5068928419 @default.
- W2404805773 creator A5081729071 @default.
- W2404805773 creator A5084862567 @default.
- W2404805773 date "1984-09-01" @default.
- W2404805773 modified "2023-09-22" @default.
- W2404805773 title "Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide." @default.
- W2404805773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6090014" @default.
- W2404805773 hasPublicationYear "1984" @default.
- W2404805773 type Work @default.
- W2404805773 sameAs 2404805773 @default.
- W2404805773 citedByCount "12" @default.
- W2404805773 crossrefType "journal-article" @default.
- W2404805773 hasAuthorship W2404805773A5006722970 @default.
- W2404805773 hasAuthorship W2404805773A5009811110 @default.
- W2404805773 hasAuthorship W2404805773A5029738724 @default.
- W2404805773 hasAuthorship W2404805773A5036344172 @default.
- W2404805773 hasAuthorship W2404805773A5041616863 @default.
- W2404805773 hasAuthorship W2404805773A5058713571 @default.
- W2404805773 hasAuthorship W2404805773A5068928419 @default.
- W2404805773 hasAuthorship W2404805773A5081729071 @default.
- W2404805773 hasAuthorship W2404805773A5084862567 @default.
- W2404805773 hasConcept C126322002 @default.
- W2404805773 hasConcept C141071460 @default.
- W2404805773 hasConcept C143998085 @default.
- W2404805773 hasConcept C2776256026 @default.
- W2404805773 hasConcept C2776694085 @default.
- W2404805773 hasConcept C2778119113 @default.
- W2404805773 hasConcept C2778239845 @default.
- W2404805773 hasConcept C2779338040 @default.
- W2404805773 hasConcept C2781303535 @default.
- W2404805773 hasConcept C2781413609 @default.
- W2404805773 hasConcept C29730261 @default.
- W2404805773 hasConcept C71924100 @default.
- W2404805773 hasConcept C90924648 @default.
- W2404805773 hasConceptScore W2404805773C126322002 @default.
- W2404805773 hasConceptScore W2404805773C141071460 @default.
- W2404805773 hasConceptScore W2404805773C143998085 @default.
- W2404805773 hasConceptScore W2404805773C2776256026 @default.
- W2404805773 hasConceptScore W2404805773C2776694085 @default.
- W2404805773 hasConceptScore W2404805773C2778119113 @default.
- W2404805773 hasConceptScore W2404805773C2778239845 @default.
- W2404805773 hasConceptScore W2404805773C2779338040 @default.
- W2404805773 hasConceptScore W2404805773C2781303535 @default.
- W2404805773 hasConceptScore W2404805773C2781413609 @default.
- W2404805773 hasConceptScore W2404805773C29730261 @default.
- W2404805773 hasConceptScore W2404805773C71924100 @default.
- W2404805773 hasConceptScore W2404805773C90924648 @default.
- W2404805773 hasIssue "9" @default.
- W2404805773 hasLocation W24048057731 @default.
- W2404805773 hasOpenAccess W2404805773 @default.
- W2404805773 hasPrimaryLocation W24048057731 @default.
- W2404805773 hasRelatedWork W2083033314 @default.
- W2404805773 hasRelatedWork W2083552799 @default.
- W2404805773 hasRelatedWork W2124411053 @default.
- W2404805773 hasRelatedWork W2263955356 @default.
- W2404805773 hasRelatedWork W2314517044 @default.
- W2404805773 hasRelatedWork W2381460883 @default.
- W2404805773 hasRelatedWork W2404805773 @default.
- W2404805773 hasRelatedWork W2417697013 @default.
- W2404805773 hasRelatedWork W4214942838 @default.
- W2404805773 hasRelatedWork W99172917 @default.
- W2404805773 hasVolume "68" @default.
- W2404805773 isParatext "false" @default.
- W2404805773 isRetracted "false" @default.
- W2404805773 magId "2404805773" @default.
- W2404805773 workType "article" @default.